Latest News
GHO Capital Invests in German Pharmaceutical Packaging Firm Sanner
Wednesday 27 October 2021

London-based specialist investor Global Healthcare Opportunities (GHO Capital Partners LLP) has invested in Germany based pharmaceutical packaging company Sanner Group, to pursue growth in market expansion, the company said.

Terms of the transaction were not disclosed.

Headquartered in Germany and leveraging its manufacturing facilities across France, Hungary and China, Sanner has developed from a provider of desiccant closures and effervescent tablet packaging into a provider of customised solutions in the areas of Medical and Diagnostics, Consumer Healthcare and Pharma.

Today, Sanner produces more than four bn component parts each year and has over 600 employees.

Sanner has recorded significant sales growth in recent years, with sales in 2020 increasing by more than 15% from 2019.

The business is set to continue to deliver significant growth, benefitting from an attractive product portfolio and long-standing relationships with its diversified, blue chip customer base.

Following the acquisition, GHO will work closely with existing management and the Sanner family, who remain closely involved with the business.

GHO will support Sanner in accelerating growth plans through the expansion of manufacturing sites in Germany and China, and developing capabilities to facilitate expansion in US markets.

Leveraging Sanner's extensive R and D and manufacturing capabilities, GHO will support management to accelerate product expansion initiatives, sales and investment in business development to deliver margin improvements and increase capacity to drive growth.

Wilkie Farr and Gallagher acted as legal advisor to GHO, Roland Berger as commercial advisor, Deloitte LLP as financial and tax advisor and ERM as ESG advisor.

Rittershaus acted as legal advisors to Sanner and Solid Trust as M and A advisors.
Date Published: 27/10/2021